SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005210
Filing Date
2020-05-05
Accepted
2020-05-05 16:31:22
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q agrx-20200331x10q.htm 10-Q 933397
2 EX-31.1 agrx-20200331ex311d74d92.htm EX-31.1 11993
3 EX-31.2 agrx-20200331ex3121c3530.htm EX-31.2 12034
4 EX-32.1 agrx-20200331ex32117844b.htm EX-32.1 6872
5 EX-32.2 agrx-20200331ex322db7938.htm EX-32.2 6926
  Complete submission text file 0001558370-20-005210.txt   3456991

Data Files

Seq Description Document Type Size
6 EX-101.INS agrx-20200331.xml EX-101.INS 525339
7 EX-101.SCH agrx-20200331.xsd EX-101.SCH 37066
8 EX-101.CAL agrx-20200331_cal.xml EX-101.CAL 32537
9 EX-101.DEF agrx-20200331_def.xml EX-101.DEF 115823
10 EX-101.LAB agrx-20200331_lab.xml EX-101.LAB 319859
11 EX-101.PRE agrx-20200331_pre.xml EX-101.PRE 221094
Mailing Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715
Business Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36464 | Film No.: 20849383
SIC: 2834 Pharmaceutical Preparations